Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine with PRF for Acute/Subacute Zoster-associated Trigeminal Neuralgia
NCT06890897Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Apr 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of esketamine in trigeminal neuralgia (TN) and herpes zoster (HZ) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Numeric Rating Scale Pain Score at 1 month. Started Apr 2025; status: recruiting.
02
Drugs
esketamine
03
Conditions
trigeminal neuralgia (TN)herpes zoster (HZ)
Beyond the preview
Go deeper on NCT06890897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06890897.